Session 10: Retroperitoneal and Abdominal Sarcomas

Chair(s)

• 

  Rebecca Gladdy, MD, PhD

  Associate Professor
  Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
  Toronto, Quebec, Canada

Moderator(s)

• 

  David Gyorki, MD

  Surgical Oncologist
  Peter MacCallum Cancer Centre
  Melbourne, Victoria, Australia
• 

  Emily Keung, MD, AM (she/her/hers)

  Assistant Professor
  University of Texas MD Anderson Cancer Center
  Houston, Texas, United States

Presentations:

• 8:00 AM – 8:08 AM

  WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
  

  Young Investigator Award Winner: Deanna Ng, MD, PhD – University of Toronto

  Author: Deanna Ng, MD, PhD – University of Toronto

  Co-Author: Belkacem Acidi, MD – Gustave Roussy

  Co-Author: Dario Callegaro, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Savtaj Brar, MD – Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto

  Co-Author: Wendy Johnston, PhD – Mount Sinai Hopsital

  Co-Author: Rebecca A. Gladdy, MD, PhD – Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto

  Co-Author: Peter Chung, MD, MRCP, FRCR, FRCPC – Department of Radiation Oncology, Princess Margaret Centre, University of Toronto

  Co-Author: Charles Catton, MD (he/him/his) – Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto

  Co-Author: Matthieu Faron, MD, PhD – Department of Surgical Oncology, Institut Gustave Roussy

  Co-Author: Korosh Khalili, MD – Princess Margaret Cancer Centre

  Co-Author: Charles Honore, MD PhD – Department of Surgical Oncology, Institut Gustave Roussy

  Co-Author: Carol J. Swallow, MD, PhD – University of Toronto
• 8:08 AM – 8:10 AM

  Q&A
• 8:10 AM – 8:18 AM

  DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
  

  Co-Author: Juliana Restrepo Lopez, MD – Clínica Vida Fundación and Clínica de Oncología Astorga

  Co-Author: Francesco Barretta, PhD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Sara Iadecola, MSc – Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Marco Fiore, MD, FACS, FEBS – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Claudia Zanframundo, MD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Stefano Radaelli, N/A, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Chiara Colombo, N/A, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Roberta Sanfilippo, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Claudia Sangalli, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Marta Barisella, MD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Carlo Morosi, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Silvia Stacchiotti (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  Co-Author: Paolo G. Casali, MD – University of Milan

  Co-Author: Rosalba Miceli, N/A, MD – Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Dario Callegaro, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
• 8:18 AM – 8:20 AM

  Q&A
• 8:20 AM – 8:28 AM

  PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
  

  Author: Fabio Tirotta, MD – University Hospitals Birmingham NHS Foundation Trust

  Co-Author: James Hodson, N/A, BsC – University Hospital Birmingham NHS Foundation Trust

  Co-Author: Ahmed Al-Mukhtar, MD – Sheffield Teaching Hospital NHS Foundation Trust

  Co-Author: Gareth Ayre, MD (he/him/his) – University Hospitals Bristol NHS Foundation Trust

  Co-Author: Adam Barlow, N/A, MD – Leeds Teaching Hospitals NHS Trust

  Co-Author: Christopher Briggs, MD – University Hospital Plymouth NHS Trust

  Co-Author: Thomas Cosker, N/A, MD – Oxford University Hospital NHS Foundation Trust

  Co-Author: Palma Dileo, MD – University College London Hospitals NHS Foundation Trust

  Co-Author: Rodrigo Figueiredo, N/A, MD – The Newcastle upon Tyne Hospitals NHS Foundation Trust

  Co-Author: Jeremy French, N/A, MD – The Newcastle upon Tyne Hospitals NHS Foundation Trust

  Co-Author: Aziz Gulamhusein, MD – The Christie NHS Foundation Trust

  Co-Author: Robert Jones, N/A, MD – Aintree University Hospital

  Co-Author: Andrew J. Hayes, MD PhD – Royal Marsden Hospital

  Co-Author: Catherine Key, N/A, MD – Sheffield Teaching Hospital NHS Foundation Trust

  Co-Author: Ahmed Mahrous, N/A, MD – University Hospitals Bristol NHS Foundation Trust

  Co-Author: Hassan Z. Malik, MD (he/him/his) – Aintree University Hospital

  Co-Author: Radu Mihai, N/A, MD – Oxford University Hospital NHS Foundation Trust

  Co-Author: Karen Partington, N/A, MD – Oxford University Hospital NHS Foundation Trust

  Co-Author: Rory Rickard, OStJ KHS PhD FRCS (he/him/his) – University Hospital Plymouth NHS Trust

  Co-Author: James Roberts, N/A, MD – University College London Hospitals NHS Foundation Trust

  Co-Author: Raza Sayyed, N/A, MD – The Royal Marsden Hospital NHS Foundation Trust

  Co-Author: Arjun Shankar, N/A, MD – University College London Hospitals NHS Foundation Trust

  Co-Author: Dirk Strauss, MMed, FCS, FRCS – Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust

  Co-Author: Paul Turner, BM BS FRCR – The Newcastle upon Tyne Hospitals NHS Foundation Trust

  Co-Author: Anant Desai, MBBS MD FRCS – University Hospital Birmingham NHS Foundation Trust
• 8:28 AM – 8:30 AM

  Q&A
• 8:30 AM – 8:38 AM

  IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
  

  Author: Dario Callegaro, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Sandro Pasquali, MD, PhD (he/him/his) – Molecular Pharmacology Unit, Department of Research and Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Rosalba Miceli, N/A, MD – Department of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Silvia Brich, N/A, PhD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Alessia Bertolotti, PhD – Fondazion IRCCS Istituto Nazionale Tumori

  Co-Author: Marta Barisella, MD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Paola Collini, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Roberta Sanfilippo, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Nadia Zaffaroni, PhD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Silvia Stacchiotti (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  Co-Author: Stefano Percio, Ph.D (he/him/his) – Fondazione IRCCS Istituto Nazionale Tumori

  Co-Author: Loris De Cecco, PhD – Fondazione IRCCS Istituto Nazionale Tumori

  Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori
• 8:38 AM – 8:40 AM

  Q&A
• 8:40 AM – 8:48 AM

  LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
  

  Author: Chiara Fabbroni – Fondazione IRCCS Istituto Nazionale dei Tumori MILANO

  Co-Author: Paul Huang, N/A, n/a – The Institute for Cancer Research

  Co-Author: Axel Le Cesne, MD – Department of Medicine, Gustave Roussy

  Co-Author: Elena R. Fumagalli, N/A, MD – Istituto Nazionale Tumori

  Co-Author: Salvatore Provenzano, n/a – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

  Co-Author: Andrea Franza, MD (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

  Co-Author: Carlo Morosi, MD – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Angelo Dei Tos, N/A, MD, PhD – Azienda Ospedaliera di Padova

  Co-Author: Marta Barisella, MD (she/her/hers) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Robin Lewis L. Jones, MD – Royal Marsden Hospital and Institute of Cancer Research

  Co-Author: Benjamin Verret, n/a – Institute Gustave Roussy- paris

  Co-Author: Paolo G. Casali, MD – University of Milan

  Co-Author: Roberta Sanfilippo, MD – Fondazione IRCCS Istituto Nazionale dei Tumori
• 8:48 AM – 8:50 AM

  Q&A
• 8:50 AM – 8:58 AM

  CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
  

  Author: Mark Fairweather, MD – Brigham and Women's Hospital/Harvard Medical School

  Co-Author: Megan L. Sulciner, MD – Brigham and Women's Hospital/Harvard Medical School

  Co-Author: Marco Fiore, MD, FACS, FEBS – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Dorian Y. Garcia Ortega, MD, MSc, PhD(c),FACS – National Cancer Institute (Mexico)

  Co-Author: Samuel J. Ford, MD, PhD – University Hospitals Birmingham NHS Foundation Trust

  Co-Author: Shintaro Iwata, MD – National Cancer Center Hospital

  Co-Author: Eran Nizri, MD, PhD – Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine

  Co-Author: Vittorio Quagliuolo, MD – Istituto Clinico Humanitas

  Co-Author: Dagmar Krakorova, MD, PhD – Masaryk Memorial Cancer Institute

  Co-Author: Carolyn Nessim, MD, MSc, FRCSC, FACS (she/her/hers) – University of Ottawa

  Co-Author: Piotr Rutkowski, MD (he/him/his) – Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

  Co-Author: Kenneth Cardona, MD, FACS – Winship Cancer Institute, Emory University

  Co-Author: Edward Y. Kim, MD (he/him/his) – University of Washington/Fred Hutch Cancer Center

  Co-Author: Andrea S. Porpiglia, MD (she/her/hers) – Fox Chase Cancer Center

  Co-Author: Fabian Johnston, MD – The Johns Hopkins University School of Medicine

  Co-Author: David E. Gyorki, MD – Peter MacCallum Cancer Centre

  Co-Author: Bruno Vincenzi, MD, PhD – Università Campus Bio-Medico di Roma

  Co-Author: Kim-Fuchs Corina, MD – Inselspital, Bern University Hospital

  Co-Author: Sonja Kramer, MD – Institute of Oncology Ljubljana

  Co-Author: Dan Blazer, III, MD – Duke University Medical Center

  Co-Author: William Tseng, MD – City of Hope National Medical Center

  Co-Author: Markus Albertsmeier, MD – Ludwig-Maximilians-Universität, University Hospital

  Co-Author: Jose Antonio González, MD – Hospital de La Santa Creu I Sant Pau

  Co-Author: Daphne Hompes, MD, PhD – University Hospitals Gasthuisberg

  Co-Author: Jiping Wang, MD (he/him/his) – TARPSWG

  Co-Author: Carol J. Swallow, MD, PhD – University of Toronto

  Co-Author: Alessandro Gronchi, MD, FSSO (he/him/his) – Fondazione IRCCS Istituto Nazionale dei Tumori

  Co-Author: Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his) – Brigham and Women’s Hospital/Harvard Medical School
• 8:58 AM – 9:00 AM

  Q&A